HCV Test and Treat Utilizing Simplified HCV Patient Education

• Status: Not yet recruiting
• Trial end date: 2027-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of HCV treatment initiation and treatment completion.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Weill Medical College of Cornell University
• Collaborator: AbbVie

Criteria

Inclusion Criteria:

• Men and women age greater or equal to18 at study entry or emancipated minors over greater or equal to 16 to less or equal 70 years at study entry

• HCV antibody positive

• HCV treatment naïve (no prior treatment with an approved or investigational anti HCV medication)

Exclusion Criteria:

• Current or history of decompensated liver disease (including but not limited to encephalopathy, variceal bleeding, or ascites) prior to study entry

• History of hepatocellular carcinoma (HCC)

• Any history of active Hepatitis B or positive HBsAg positive test

• HCV RNA undetectable